Revision of the current legislation has been steered by issues that have arisen in recent years, including concerns with antimicrobial resistance and supply chain security, tested to the extreme during the COVID-19 pandemic, where patient access to medicines was a particular concern. Read more.
Compliments Squire Patton Boggs